Managing Director, 5 Prime Ventures / Venture Partner, Fidelity Biosciences
Jenny Rooke drives Life Sciences technology development as an investor, executive, and strategist. She is currently a Venture Partner at Fidelity Biosciences as well as Managing Director of 5 Prime Ventures. 5 Prime invests in early-stage life sciences technology companies with a focus on opportunities in research tools, molecular diagnostics, synthetic biology, and industrial biology. At Fidelity, Jenny focuses on early-stage life science companies on the west coast, specializing in research tools, diagnostics, and synthetic biology.
Jenny spent 4 years as a Senior Program Officer in the Global Health Discovery group at the Bill & Melinda Gates Foundation, where she worked to shape strategy and develop and manage grants in research and technology areas of central importance to the Foundation’s mission, with a focus on emerging technologies such as genetically modified organisms and synthetic biology.
Jenny had an earlier tenure at Fidelity Biosciences, focusing on diagnostics and life science tools. She served on the boards of Accuri Cytometers and U.S. Genomics, and was the liaison with Fidelity’s sister fund in India. She held earlier leadership roles at US Genomics.
Jenny earned her PhD in genetics from Yale University where she was a National Science Foundation Fellow, and holds a BS in physics from Georgia Tech.
Jenny is a member of Kauffman Fellows Class 11 and served her fellowship under mentor Stephen Knight at Fidelity Biosciences in Cambridge, MA.